title: Insights into the mechanism of onabotulinumtoxinA in chronic migraine.
abstract: OnabotulinumtoxinA has recently been approved by regulatory agencies in the UK and United States for treatment of chronic migraine based on data generated from the PREEMPT studies. As such, onabotulinumtoxinA is the only prophylactic therapy specifically approved for chronic migraine. Most headache clinicians would agree that acute episodic migraine and chronic migraine differ in their pathophysiology, etiology, diagnosis, and response to pharmacological as well as nonpharmacological therapies. Of the 7 botulinum neurotoxin serotypes, botulinum neurotoxin type A (onabotulinumtoxinA) has been the most thoroughly investigated in preclinical and clinical studies. Based on preclinical studies, onabotulinumtoxinA is known to inhibit the release of excitatory neurotransmitters from both motor and sensory neurons by preventing vesicle fusion to the cell membrane. In addition to the well-documented myorelaxant effects of this neurotoxin, onabotulinumtoxinA can exert a direct analgesic effect that likely involves inhibition of primary and secondary nociceptive neurons. The inhibitory effects of onabotulinumtoxinA are also likely to involve suppressing the activity of myogenic trigger points and decreasing the persistent nociceptive barrage that promotes and maintains central sensitization. This article describes possible mechanisms to explain how onabotulinumtoxinA functions as a therapy for chronic migraine and considers why treatment with the neurotoxin is not effective in some chronic migraineurs.
authors.affiliation: Center for Biomedical & Life Sciences, Missouri State University, Springfield, MO 65806, USA. pauldurham@missouristate.edu
authors.forename: Paul L
authors.initials: PL
authors.lastname: Durham
authors.forename: Roger
authors.initials: R
authors.lastname: Cady
mesh_terms: D019274:Botulinum Toxins, Type A / Q000008:administration & dosage*; D002908:Chronic Disease; D006801:Humans; D007273:Injections, Intramuscular; D008881:Migraine Disorders / Q000188:drug therapy* / Q000503:physiopathology; D016896:Treatment Outcome; D061028:Trigger Points / Q000502:physiology
chemical_list: D019274:Botulinum Toxins, Type A
references.citation: Brain Res. 2009 Feb 9;1253:48-59
references.pmid: 19084510
references.citation: Semin Cell Biol. 1994 Aug;5(4):221-9
references.pmid: 7994006
references.citation: Nat Med. 2002 Feb;8(2):136-42
references.pmid: 11821897
references.citation: Eur J Neurol. 2006 Dec;13 Suppl 4:1-9
references.pmid: 17112344
references.citation: Nat Neurosci. 2002 May;5(5):425-30
references.pmid: 11953753
references.citation: Am J Physiol Heart Circ Physiol. 2001 Nov;281(5):H2124-32
references.pmid: 11668074
references.citation: J Neurophysiol. 2007 Aug;98(2):794-806
references.pmid: 17553942
references.citation: Open Pain J. 2009 Jan 1;2:7-31
references.pmid: 21179400
references.citation: Crit Rev Oral Biol Med. 2000;11(1):57-91
references.pmid: 10682901
references.citation: Cephalalgia. 2010 Jul;30(7):804-14
references.pmid: 20647171
references.citation: Can J Neurol Sci. 1999 Nov;26 Suppl 3:S7-11
references.pmid: 10563227
references.citation: Neuroscience. 2008 Dec 2;157(3):542-55
references.pmid: 18938228
references.citation: Biophys J. 2009 Mar 18;96(6):2449-56
references.pmid: 19289069
references.citation: Headache. 2003 Jul-Aug;43 Suppl 1:S9-15
references.pmid: 12887389
references.citation: J Appl Physiol (1985). 2005 Nov;99(5):1977-84
references.pmid: 16037403
references.citation: Eur J Neurosci. 2007 Jul;26(1):142-54
references.pmid: 17614945
references.citation: Headache. 2003 Jul-Aug;43 Suppl 1:S16-24
references.pmid: 12887390
references.citation: Curr Pain Headache Rep. 2007 Oct;11(5):365-72
references.pmid: 17894927
references.citation: Neuroscience. 2011 Jul 14;186:201-7
references.pmid: 21539899
references.citation: Pharmacol Biochem Behav. 2009 Dec;94(2):234-8
references.pmid: 19732788
references.citation: Neurotoxicology. 2005 Oct;26(5):785-93
references.pmid: 16002144
references.citation: Handb Exp Pharmacol. 2009;(194):451-91
references.pmid: 19655115
references.citation: Headache. 2008 Apr;48(4):523-8
references.pmid: 18377378
references.citation: Cephalalgia. 2010 Jul;30(7):793-803
references.pmid: 20647170
references.citation: Curr Rheumatol Rep. 2002 Aug;4(4):313-21
references.pmid: 12126583
references.citation: J Biol Chem. 2001 Apr 20;276(16):13476-82
references.pmid: 11278807
references.citation: Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):7163-8
references.pmid: 9618556
references.citation: BMC Musculoskelet Disord. 2010 Oct 12;11:234
references.pmid: 20939890
references.citation: Jpn Dent Sci Rev. 2010 Feb 1;46(1):86
references.pmid: 20161683
references.citation: Cephalalgia. 2007 Jun;27(6):492-503
references.pmid: 17428299
references.citation: Headache. 2003 Sep;43(8):853-60
references.pmid: 12940806
references.citation: Nat Rev Drug Discov. 2003 Dec;2(12):973-85
references.pmid: 14654796
references.citation: Headache. 2004 Jan;44(1):35-42; discussion 42-3
references.pmid: 14979881
references.citation: Curr Neurol Neurosci Rep. 2010 Sep;10(5):338-44
references.pmid: 20567945
references.citation: Headache. 2007 Feb;47(2):170-80
references.pmid: 17300356
references.citation: J Mol Neurosci. 2006;30(1-2):215-8
references.pmid: 17192679
references.citation: Biochimie. 2000 May;82(5):427-46
references.pmid: 10865130
references.citation: Headache. 2007 Apr;47(4):486-99
references.pmid: 17445098
references.citation: Headache. 2008 Jun;48(6):778-82
references.pmid: 18484982
references.citation: J Cell Sci. 2007 Aug 15;120(Pt 16):2864-74
references.pmid: 17666428
references.citation: Pain. 2006 Nov;125(1-2):82-8
references.pmid: 16750294
references.citation: J Neurosci. 2009 Apr 15;29(15):4981-92
references.pmid: 19369567
references.citation: Acta Neuropathol. 2010 Jan;119(1):37-53
references.pmid: 19847447
references.citation: Toxicon. 1997 Sep;35(9):1373-412
references.pmid: 9403963
references.citation: J Neurophysiol. 1986 Feb;55(2):227-43
references.pmid: 3950689
references.citation: Headache. 2007 Jul-Aug;47(7):1008-23; discussion 24-5
references.pmid: 17635592
references.citation: Headache. 2009 Jan;49(1):5-20
references.pmid: 19125874
references.citation: Neurology. 2009 Feb 3;72(5 Suppl):S14-20
references.pmid: 19188563
references.citation: J Biol Chem. 2003 Jan 10;278(2):1363-71
references.pmid: 12381720